Utilization of AMSC to Enhance Rotator Cuff Repair - Safety and Efficacy
Phase 1
Terminated
- Conditions
- Rotator Cuff Tear
- Interventions
- Drug: Suspension of human autologous MSC 3P
- First Posted Date
- 2019-02-12
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Bioinova, s.r.o.
- Target Recruit Count
- 9
- Registration Number
- NCT03838666
Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis
Phase 1
Completed
- Conditions
- Motor Neuron Disease, Amyotrophic Lateral Sclerosis
- Interventions
- Biological: Suspension of human autologous MSC 3P in 1.5 ml
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2019-02-12
- Lead Sponsor
- Bioinova, s.r.o.
- Target Recruit Count
- 26
- Registration Number
- NCT03828123
Utilization of Autologous Mesenchymal Cells in Posterolateral Spinal Fusion in Degenerative Spine Disease
Phase 1
Terminated
- Conditions
- Degenerative Disc Disease
- Interventions
- Drug: Suspension of human autologous MSC 3P in 1.5 ml
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Bioinova, s.r.o.
- Target Recruit Count
- 10
- Registration Number
- NCT03827096
© Copyright 2025. All Rights Reserved by MedPath